These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8752102)

  • 1. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
    Gu JG; Nath A; Geiger JD
    J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]adenosine transport in synaptoneurosomes of postmortem human brain.
    Gu JG; Kala G; Geiger JD
    J Neurochem; 1993 Jun; 60(6):2232-7. PubMed ID: 8492128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport and metabolism of D-[3H]adenosine and L-[3H]adenosine in rat cerebral cortical synaptoneurosomes.
    Gu JG; Geiger JD
    J Neurochem; 1992 May; 58(5):1699-705. PubMed ID: 1560227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
    Kalsi KK; Smolenski RT; Yacoub MH
    Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
    Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
    Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
    Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
    Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
    Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
    J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations.
    Gu JG; Foga IO; Parkinson FE; Geiger JD
    J Neurochem; 1995 May; 64(5):2105-10. PubMed ID: 7722493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
    Correia-de-Sá P; Ribeiro JA
    Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat.
    Geiger JD; Johnston ME; Yago V
    J Neurochem; 1988 Jul; 51(1):283-91. PubMed ID: 3379409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside transporter-mediated uptake and release of [3H]L-adenosine in DDT1 MF-2 smooth muscle cells.
    Foga IO; Geiger JD; Parkinson FE
    Eur J Pharmacol; 1996 Dec; 318(2-3):455-60. PubMed ID: 9016938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
    Parkinson FE; Geiger JD
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1397-401. PubMed ID: 8667202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
    Dawicki DD; Agarwal KC; Parks RE
    Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]adenosine transport in DDT1 MF-2 smooth muscle cells: inhibition by metabolites of propentofylline.
    Parkinson FE; Mukherjee K; Geiger JD
    Eur J Pharmacol; 1996 Jul; 308(1):97-102. PubMed ID: 8836637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]dipyridamole binding to nucleoside transporters from guinea-pig and rat lung.
    Shi MM; Young JD
    Biochem J; 1986 Dec; 240(3):879-83. PubMed ID: 3827876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that adenine nucleotides modulate nucleoside-transporter function. Characterization of uridine transport in chromaffin cells and plasma membrane vesicles.
    Delicado EG; Casillas T; Sen RP; Miras-Portugal MT
    Eur J Biochem; 1994 Oct; 225(1):355-62. PubMed ID: 7925456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.